Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Lineage Cell Therapeutics, Inc. Common Stock
(NY:
LCTX
)
1.275
+0.075 (+6.25%)
Streaming Delayed Price
Updated: 3:16 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Lineage Cell Therapeutics, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Two Biotech Stocks Poised For Big Moves On Monday
↗
June 23, 2025
Via
Benzinga
OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025
June 23, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Beyond The Numbers: 7 Analysts Discuss Lineage Cell Therapeutics Stock
↗
March 11, 2025
Via
Benzinga
Forecasting The Future: 6 Analyst Projections For Lineage Cell Therapeutics
↗
January 31, 2025
Via
Benzinga
Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium
June 05, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC
May 14, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
The Analyst Verdict: Lineage Cell Therapeutics In The Eyes Of 4 Experts
↗
January 03, 2025
Via
Benzinga
Lineage Cell Therapeutics's Earnings Outlook
↗
November 13, 2024
Via
Benzinga
Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Examining the Future: Lineage Cell Therapeutics's Earnings Outlook
↗
May 12, 2025
Via
Benzinga
Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025
May 01, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
May 12, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium
April 22, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Which stocks are moving after the closing bell on Wednesday?
↗
April 16, 2025
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
April 21, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 15, 2025
Via
Benzinga
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 10, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For March 10, 2025
↗
March 10, 2025
Via
Benzinga
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025
March 05, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference
February 04, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury
February 11, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering
January 27, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics Issues Letter to Stockholders
January 06, 2025
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering
November 21, 2024
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 20, 2024
Via
Benzinga
Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering
November 20, 2024
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 14, 2024
From
Lineage Cell Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For November 14, 2024
↗
November 14, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
